ATII Holdings Amends $100 Million PIPE Deal for Forge Nano Merger
Archimedes Tech SPAC Partners II updates its $100 million PIPE investment terms with Forge Nano, introducing pre-funded warrants ahead of the shareholder votes.
Latest News
Every story from SEC filings, newest first.
Quantumsphere Acquisition Corp to Merge with Fortune Favor in $600 Million Deal
SSR Mining to Acquire Roxmore Resources in $464 Million Strategic Nevada Expansion
Bumble Shares Skyrocket 56% After Ithaca Holdings to Acquire Company in $1.3 Billion Deal
Ondas Inc. Reports Q2 Revenue Surge to $83.8 Million and Raises 2026 Guidance
Partnership
Ondas Inc. and Palantir Launch Regna AI to Deliver Sovereign Defense Intelligence
Ondas Inc. and Palantir establish Regna AI, a standalone entity focused on sovereign AI for defense sectors using Palantir's AIP and Ondas' autonomous tech.
Regulatory Approval
SAB Biotherapeutics (SABS) Secures FDA Fast Track for SAB-142 Diabetes Immunotherapy
SAB Biotherapeutics (SABS) secures FDA Fast Track designation for SAB-142, a Stage 3 type 1 diabetes immunotherapy. Topline Phase 2b data expected in 2H 2027.
Clinical Trial Data
First Tracks Biotherapeutics Shares Surge 6.91% on Positive Phase 1b Celiac Disease Data
First Tracks Biotherapeutics (TRAX) rose 6.91% on positive Phase 1b results for ANB033 in Celiac Disease. The firm expects a cash runway through Q2 2028.
Nasdaq/NYSE Compliance Warning
Eightco Holdings Inc. Regains Nasdaq Compliance After Ten-Day $1.00 Price Streak
Eightco Holdings Inc. (ORBS) has regained Nasdaq compliance after its stock closed at or above $1.00 for ten days, closing a deficiency notice from August 2026.
Regulatory Approval
Mirum Pharmaceuticals Meets Phase 3 EXPAND Endpoints for LIVMARLI; sNDA Planned for 2027
Mirum Pharmaceuticals announced positive Phase 3 results for LIVMARLI, achieving 1.81-point pruritus improvement. A supplemental NDA is targeted for early 2027.
M&A Deal
Kimberly-Clark Advances $48.7 Billion Kenvue Acquisition with $7 Billion Debt Exchange
Kimberly-Clark progresses its $48.7 billion Kenvue acquisition, securing consents for a $7 billion debt exchange. The deal is slated for a Q4 2026 closing.
Earning Call
TTM Technologies Reports Record Q2 2026 Revenue of $1 Billion Amid Data Center Surge
TTM Technologies achieves record Q2 2026 revenue of $1 billion, driven by a 91% surge in data center demand and raised full-year guidance to $4.4 billion.
Financial Results
Norris Industries Reports $0.09 Million Q2 Revenue Amid Widening Net Loss
Norris Industries (NRIS) reports $0.09 million in Q2-26 revenue. The company faces a $5.25 million stockholders deficit while maintaining Texas oil operations.
Capital Raise
ADC Therapeutics Secures $86.6 Million PIPE to Extend Cash Runway into 2029
ADC Therapeutics (ADCT) secures an $86.6 million private placement to fund ZYNLONTA Phase 3 clinical trials and extend its cash runway into the year 2029.
Financial Results
Nurix Therapeutics Swings to $549.8M Net Income in Q3 2026 on License Revenue Surge
Nurix Therapeutics reports Q3 2026 net income of $549.8 million, a significant turnaround from a prior loss, driven by $673.1 million in quarterly revenue.
Earning Call
IonQ Reports 287 Percent Revenue Surge to $80.1 Million Following SkyWater Merger
IonQ reports Q2 2026 revenue of $80.1 million, a 287 percent year-over-year increase, while completing the $1.8 billion acquisition of SkyWater Technology.
Financial Results
OZ Vision Inc. Reports $0.05 Million Revenue and 10.6% Net Loss Improvement for FY 2026
OZ Vision Inc. reports $0.05 million in revenue for fiscal 2026. Net loss narrowed 10.6% to -$0.06 million while auditors issued a going concern warning.
Capacity Expansion
TTM Technologies Shares Rise 5% After Investing $400 Million to Scale AI Infrastructure
TTM Technologies (TTMI) announces a $400 million incremental investment to expand AI interconnect manufacturing across China and Malaysia through 2029.
Financial Results
Domino's Pizza Reports $1.19 Billion Revenue and 9.2% Net Income Growth for Q3 2026
Domino's Pizza (DPZ) reports Q3 2026 revenue of $1,186 million and net income of $152.18 million. Diluted EPS rose to $4.60 amid a $1.33 billion debt shift.
Partnership
Humana Partners with BlackRock in $2.8 Billion CenterWell Primary Care Joint Venture
Humana enters a $2.8 billion joint venture with BlackRock to manage CenterWell clinics, removing put options and affirming its 2026 Adjusted EPS guidance of $9.00.
